INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 457m ago
House PTR57m ago
SEC 13F56m ago
Robinhood Chain56m ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.70B / 21S · 11 late91 trades$26.34M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 33S33 trades$5.33M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  7. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  8. SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M

Form 4 transactions

68,923 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
BB
Bunker Mathew BSENIOR VP, OPERATIONS
MCHPMICROCHIP TECHNOLOGY INC
Grant or award
A—
1,692 sh
Jul 1, 2026Jul 6, 2026
Page 588 of 1724
← PrevNext →
traded Jul 1, 2026
+5d
SEC Form 4

Evidence

10
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$338K
1,081 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

10
CK
Clark KyleDirector, SEE REMARKS
BETABETA Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$261K
15.0K sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

10
RG
Renfroe Sean GGENERAL COUNSEL
TXRHTexas Roadhouse, Inc.
Tax withholding · 10b5-1 plan
F$70K
367 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

10
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$284K
900 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

10
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$349K
1,119 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

10
LM
Lin MarkEVP and CFO
SMTCSEMTECH CORP
Option exercise · 10b5-1 plan
M—
3,164 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

10
SS
Sahni Sanjeev SinghDirector, Chief Executive Officer
XMTRXometry, Inc.
Grant or award
A—
40.5K sh
Jul 3, 2026Jul 6, 2026
traded Jul 3, 2026
+3dSEC Form 4

Evidence

10
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
49.2K sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

9
HA
Hasson AviDirector
TSEMTOWER SEMICONDUCTOR LTD
Grant or award
A—
814 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

9
RH
Robinson Mark HaymondGeneral Counsel and Secretary
GMEGameStop Corp.
Open-market sale · 10b5-1 plan
SELL$90K
3,957 sh
Jul 6, 2026Jul 6, 2026
traded Jul 6, 2026
+0dSEC Form 4

Evidence

9
EC
Ellwanger Russell CraigChief Executive Officer
TSEMTOWER SEMICONDUCTOR LTD
Grant or award
A—
22.9K sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

9
NB
Nelson Kenza BemisSVP, General Counsel
HBIA.PKHILLS BANCORPORATION
Grant or award
A$1,984
50 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

9
VM
Vakrat Wolkin MichalDirector
TSEMTOWER SEMICONDUCTOR LTD
Grant or award
A—
814 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

9
LR
Lewis Michelle ReneeChief Accounting Officer
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$186K
4,137 sh
Jul 6, 2026Jul 6, 2026
traded Jul 6, 2026
+0dSEC Form 4

Evidence

9
RM
Roth James MChief Revenue Officer
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
80.9K sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

9
PY
Park Angie YChief Financial Officer
ACNAccenture plc
Grant or award
A$27K
202 sh
Jul 5, 2026Jul 6, 2026
traded Jul 5, 2026
+1dSEC Form 4

Evidence

9
HM
Hollywood MarkEVP & Chief Operating Officer
ZYMEZymeworks Inc.
Grant or award
A$21K
939 sh
Jul 6, 2026Jul 6, 2026
traded Jul 6, 2026
+0dSEC Form 4

Evidence

9
PR
Powell RikkiChief Financial Officer
SSTKShutterstock, Inc.
Tax withholding
F$12K
1,233 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

9
MR
Marion Josh R.SVP and General Counsel
KOSKosmos Energy Ltd.
Grant or award · 10b5-1 plan
A—
64.2K sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

9
HM
Hancock MarkDirector, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$577K
12.8K sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

9
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$27K
100 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

9
AI
Avner IrisDirector
TSEMTOWER SEMICONDUCTOR LTD
Grant or award
A—
814 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

9
EA
Elstein AmirDirector
TSEMTOWER SEMICONDUCTOR LTD
Grant or award
A—
1,222 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

9
MM
McKim Dale M. IIIEVP, CFO & Treasurer
CHMGCHEMUNG FINANCIAL CORP
Tax withholding
F$14K
187 sh
Jul 3, 2026Jul 6, 2026
traded Jul 3, 2026
+3dSEC Form 4

Evidence

9
CY
Chelouche YoavDirector
TSEMTOWER SEMICONDUCTOR LTD
Grant or award
A—
814 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

9
GR
Globokar Brian R.SVP, Dr of Trust & Wealth Mgmt
HBIA.PKHILLS BANCORPORATION
Grant or award
A$2,250
57 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

9
RM
Roth James MChief Revenue Officer
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
30.6K sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

9
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Tax withholding · 10b5-1 plan
F$63K
21.3K sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

9
PT
Prengel Eric TheodoreChief Financial Officer
PDPagerDuty, Inc.
Grant or award
A—
600.0K sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

8
BS
Beatty Jonathan SMD, Head of Advisor Services
SCHWSCHWAB CHARLES CORP
Open-market sale · 10b5-1 plan
SELL$200K
2,000 sh
Jul 6, 2026Jul 6, 2026
traded Jul 6, 2026
+0dSEC Form 4

Evidence

8
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Option exercise · 10b5-1 plan
M$261K
5,000 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

8
MR
Marion Josh R.SVP and General Counsel
KOSKosmos Energy Ltd.
Open-market sale · 10b5-1 plan
SELL$51K
25.0K sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

8
WM
Wittmann MichaelChief Operating Officer
INDIindie Semiconductor, Inc.
Option exercise
M—
12.5K sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

8
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Open-market sale · 10b5-1 plan
SELL$5,455
137 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

8
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Tax withholding
F$33K
1,838 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

8
WM
Wittmann MichaelChief Operating Officer
INDIindie Semiconductor, Inc.
Option exercise
M—
65.0K sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

8
BS
Beatty Jonathan SMD, Head of Advisor Services
SCHWSCHWAB CHARLES CORP
Open-market sale · 10b5-1 plan
SELL$194K
2,000 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

8
JD
Johnston James DavidExecutive VP, GC, CCO and Secy
SMCSummit Midstream Corp
Open-market sale · 10b5-1 plan
SELL$77K
2,600 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

7
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$122K
396 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence